Literature DB >> 12947145

Chronic obstructive pulmonary disease * 12: New treatments for COPD.

P J Barnes1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12947145      PMCID： PMC1746809          DOI： 10.1136/thorax.58.9.803

Source DB:  PubMed          Journal:  Thorax        ISSN： 0040-6376            Impact factor:   9.139


× No keyword cloud information.
  79 in total

Review 1.  The biology of chemokines and their receptors.

Authors:  D Rossi; A Zlotnik
Journal:  Annu Rev Immunol       Date:  2000       Impact factor: 28.527

2.  Kinase regulation in inflammatory response.

Authors:  M Delhase; N Li; M Karin
Journal:  Nature       Date:  2000-07-27       Impact factor: 49.962

Review 3.  Immunosuppressive and anti-inflammatory effects of cyclic AMP phosphodiesterase (PDE) type 4 inhibitors.

Authors:  J E Souness; D Aldous; C Sargent
Journal:  Immunopharmacology       Date:  2000-05

Review 4.  Effectiveness of interventions to help people stop smoking: findings from the Cochrane Library.

Authors:  T Lancaster; L Stead; C Silagy; A Sowden
Journal:  BMJ       Date:  2000-08-05

Review 5.  Chronic obstructive pulmonary disease.

Authors:  P J Barnes
Journal:  N Engl J Med       Date:  2000-07-27       Impact factor: 91.245

Review 6.  Inhibition of p38 MAP kinase as a therapeutic strategy.

Authors:  J C Lee; S Kumar; D E Griswold; D C Underwood; B J Votta; J L Adams
Journal:  Immunopharmacology       Date:  2000-05

Review 7.  Bupropion: a review of its use in the management of smoking cessation.

Authors:  K J Holm; C M Spencer
Journal:  Drugs       Date:  2000-04       Impact factor: 9.546

8.  Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial.

Authors:  P S Burge; P M Calverley; P W Jones; S Spencer; J A Anderson; T K Maslen
Journal:  BMJ       Date:  2000-05-13

Review 9.  Infliximab: a review of its use in the management of rheumatoid arthritis.

Authors:  A Markham; H M Lamb
Journal:  Drugs       Date:  2000-06       Impact factor: 9.546

10.  Long-acting bronchodilation with once-daily dosing of tiotropium (Spiriva) in stable chronic obstructive pulmonary disease.

Authors:  M R Littner; J S Ilowite; D P Tashkin; M Friedman; C W Serby; S S Menjoge; T J Witek
Journal:  Am J Respir Crit Care Med       Date:  2000-04       Impact factor: 21.405
View more
  17 in total

Review 1.  Phosphoinositide 3-kinase signalling in lung disease: leucocytes and beyond.

Authors:  David A Medina-Tato; Stephen G Ward; Malcolm L Watson
Journal:  Immunology       Date:  2007-08       Impact factor: 7.397

2.  Targeted drug delivery to emphysematous lungs: Inhibition of MMPs by doxycycline loaded nanoparticles.

Authors:  Vaideesh Parasaram; Nasim Nosoudi; Renee J LeClair; Andrew Binks; Naren Vyavahare
Journal:  Pulm Pharmacol Ther       Date:  2016-06-25       Impact factor: 3.410

3.  Tiotropium Bromide/Olodaterol (Stiolto Respimat): Once-Daily Combination Therapy for the Maintenance of COPD.

Authors:  Juan F Mosley; Lillian L Smith; Brittany N Dutton
Journal:  P T       Date:  2016-02

Review 4.  Inhaled corticosteroids in chronic obstructive pulmonary disease: is there a clinical benefit?

Authors:  S F Paul Man; Don D Sin
Journal:  Drugs       Date:  2005       Impact factor: 9.546

5.  Enhancement of COPD biological networks using a web-based collaboration interface.

Authors:  Stephanie Boue; Brett Fields; Julia Hoeng; Jennifer Park; Manuel C Peitsch; Walter K Schlage; Marja Talikka; Ilona Binenbaum; Vladimir Bondarenko; Oleg V Bulgakov; Vera Cherkasova; Norberto Diaz-Diaz; Larisa Fedorova; Svetlana Guryanova; Julia Guzova; Galina Igorevna Koroleva; Elena Kozhemyakina; Rahul Kumar; Noa Lavid; Qingxian Lu; Swapna Menon; Yael Ouliel; Samantha C Peterson; Alexander Prokhorov; Edward Sanders; Sarah Schrier; Golan Schwaitzer Neta; Irina Shvydchenko; Aravind Tallam; Gema Villa-Fombuena; John Wu; Ilya Yudkevich; Mariya Zelikman
Journal:  F1000Res       Date:  2015-01-29

Review 6.  Phosphodiesterase 4 inhibitors in chronic obstructive pulmonary disease: a new approach to oral treatment.

Authors:  Graeme P Currie; Claire A Butler; Wendy J Anderson; Chris Skinner
Journal:  Br J Clin Pharmacol       Date:  2008-03-13       Impact factor: 4.335

Review 7.  Potential role of stem cells in management of COPD.

Authors:  Tillie L Hackett; Darryl A Knight; Don D Sin
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2010-04-07

8.  Modelling the 5-year cost effectiveness of tiotropium, salmeterol and ipratropium for the treatment of chronic obstructive pulmonary disease in Spain.

Authors:  Maureen P M H Rutten-van Mölken; Jan B Oostenbrink; Marc Miravitlles; Brigitta U Monz
Journal:  Eur J Health Econ       Date:  2007-03-17

9.  The Ethic of Access: An AIDS Activist Won Public Access to Experimental Therapies, and This Must Now Extend to Psychedelics for Mental Illness.

Authors:  Morgan Campbell; Monnica T Williams
Journal:  Front Psychiatry       Date:  2021-07-05       Impact factor: 4.157

Review 10.  Pathophysiological roles of microvascular alterations in pulmonary inflammatory diseases: possible implications of tumor necrosis factor-alpha and CXC chemokines.

Authors:  Kanami Orihara; Akio Matsuda
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2008
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.